Invention Grant
- Patent Title: Centromere/kinetochore protein genes for cancer diagnosis, prognosis and treatment selection
-
Application No.: US15312138Application Date: 2015-05-18
-
Publication No.: US11434535B2Publication Date: 2022-09-06
- Inventor: Weiguo Zhang , Gary Karpen , Jian-Hua Mao
- Applicant: The Regents of the University of California
- Applicant Address: US CA Oakland
- Assignee: The Regents of the University of California
- Current Assignee: The Regents of the University of California
- Current Assignee Address: US CA Oakland
- Agency: Kilpatrick Townsend & Stockton LLP
- International Application: PCT/US2015/031413 WO 20150518
- International Announcement: WO2015/179312 WO 20151126
- Main IPC: C12Q1/6886
- IPC: C12Q1/6886 ; G01N33/574

Abstract:
The invention described in the application relates to a panel of gene expression markers for patient with a tumor. The invention thus provides methods and compositions, e.g., kits, for evaluating gene expression levels of the markers and methods of using such gene expression levels to evaluate the likelihood of disease progression or response to chemotherapy or radiation therapy. Such information can be used in determining prognosis and treatment options for cancer patients.
Public/Granted literature
- US20170175202A1 CENTROMERE/KINETOCHORE PROTEIN GENES FOR CANCER DIAGNOSIS, PROGNOSIS AND TREATMENT SELECTION Public/Granted day:2017-06-22
Information query
IPC分类: